Clinical Trial Update: Ultralow Dose PET Imaging of 18F-flurpiridaz [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ultralow dose PET imaging using the radiotracer 18F-flurpiridaz, currently enrolling by invitation. The trial targets corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• 18F-flurpiridaz (flurpiridaz)

Snippet

Sponsor: Akiva Mintz | Conditions: Healthy Volunteer, Coronary Arterial Disease | Phase 2 | Status: ENROLLING_BY_INVITATION